Prosecution Insights
Last updated: August 18, 2026

Examiner: DICKENS, AMELIA NICOLE

Tech Center 1600 • Art Units: 1645 1671

This examiner grants 47% of resolved cases

Performance Statistics

47.2%
Allow Rate
-12.8% vs TC avg
167
Total Applications
+22.4%
Interview Lift
1267
Avg Prosecution Days
Based on 123 resolved cases, 2023–2026

Rejection Statute Breakdown

6.6%
§101 Eligibility
20.3%
§102 Novelty
22.4%
§103 Obviousness
37.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18665951 PNEUMOCOCCAL CONJUGATE VACCINES AND METHODS OF USE THEREOF Non-Final OA Merck Sharp & Dohme LLC
17335578 METHODS FOR ASSESSING EFFICACY OF A DRUG IN VIVO BY MONITORING ADME PROTEINS IN EXTRACELLULAR VESICLES Final Rejection Purdue Research Foundation
17788224 PROCESS TO IDENTIFY CONSORTIA OF PROBIOTIC STRAINS SUITABLE FOR GLUTEN DEGRADATION Final Rejection Evonik Operations GmbH
18466984 METHOD FOR PRODUCING FOREIGN PROTEIN USING E. COLI Final Rejection KANEKA CORPORATION
18286005 ENCAPSULATED MICROBIAL COMPOSITIONS AND METHODS OF MAKING THE SAME Non-Final OA Monsanto Technology LLC
18404140 GENOMIC SEQUENCES FOR YEAST PROBIOTICS Non-Final OA Worcester Polytechnic Institute
18167664 Microbially Induced Inflammation Produces Changes in Distinct Healthy Tissues in Human Oral Cavity Final Rejection Colgate-Palmolive Company
18328308 ANTAGONIST MICROORGANISMS FOR INHIBITING FIRE BLIGHT AND COMPOSITION FOR INHIBITING FIRE BLIGHT WITH THE SAME AS ACTIVE INGREDIENT Non-Final OA KNU-INDUSTRY COOPERATION FOUNDATION
18266167 COMPOSITION COMPRISING BACTERIUM OF THE GENUS ACIDIPROPIONIBACTERIUM OR PROCESSED PRODUCT THEREOF Non-Final OA MEIJI CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month